RhumbLine Advisers’s Alexion Pharmaceuticals ALXN Stock Holding History

RhumbLine Advisers’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-421,197	Closed	-$77.4M	–	3059
2021 Q2	$77.4M	Sell	421,197 -7,839	-2%	-$1.35M	0.1%	169
2021 Q1	$65.6M	Sell	429,036 -20,848	-5%	-$3.22M	0.09%	198
2020 Q4	$70.3M	Sell	449,884 -37,144	-8%	-$4.77M	0.1%	173
2020 Q3	$55.7M	Sell	487,028 -6,876	-1%	-$742K	0.09%	198
2020 Q2	$55.4M	Buy	493,904 +34,800	+8%	+$3.69M	0.09%	187
2020 Q1	$41.2M	Buy	459,104 +10,666	+2%	+$1.05M	0.09%	209
2019 Q4	$48.5M	Buy	448,438 +3,075	+0.7%	+$329K	0.08%	220
2019 Q3	$43.6M	Buy	445,363 +22,773	+5%	+$2.57M	0.08%	237
2019 Q2	$55.4M	Sell	422,590 -1,284	-0.3%	-$165K	0.1%	188
2019 Q1	$57.3M	Buy	423,874 +5,183	+1%	+$644K	0.11%	171
2018 Q4	$40.8M	Buy	418,691 +7,608	+2%	+$899K	0.09%	208
2018 Q3	$57.1M	Buy	411,083 +2,370	+0.6%	+$297K	0.11%	184
2018 Q2	$50.7M	Buy	408,713 +13,392	+3%	+$1.57M	0.1%	195
2018 Q1	$44.1M	Sell	395,321 -8,168	-2%	-$976K	0.09%	222
2017 Q4	$48.3M	Buy	403,489 +15,174	+4%	+$1.85M	0.1%	211
2017 Q3	$54.5M	Sell	388,315 -4,040	-1%	-$549K	0.12%	181
2017 Q2	$47.7M	Buy	392,355 +5,479	+1%	+$638K	0.11%	196
2017 Q1	$46.9M	Buy	386,876 +10,282	+3%	+$1.33M	0.11%	193
2016 Q4	$46.1M	Buy	376,594 +14,255	+4%	+$1.74M	0.12%	184
2016 Q3	$44.4M	Buy	362,339 +8,418	+2%	+$1.08M	0.12%	172
2016 Q2	$41.3M	Buy	353,921 +16,819	+5%	+$2.39M	0.12%	170
2016 Q1	$46.9M	Buy	337,102 +16,262	+5%	+$2.39M	0.15%	136
2015 Q4	$61.2M	Sell	320,840 -1,378	-0.4%	-$241K	0.2%	102
2015 Q3	$50.4M	Buy	322,218 +12,249	+4%	+$2.23M	0.17%	121
2015 Q2	$56M	Sell	309,969 -24,446	-7%	-$4.22M	0.18%	113
2015 Q1	$58M	Sell	334,415 -479	-0.1%	-$86.7K	0.17%	126
2014 Q4	$62M	Sell	334,894 -5,585	-2%	-$1.03M	0.18%	119
2014 Q3	$56.5M	Sell	340,479 -6,900	-2%	-$1.13M	0.17%	127
2014 Q2	$54.3M	Buy	347,379 +40,236	+13%	+$6.35M	0.16%	145
2014 Q1	$46.7M	Sell	307,143 -9,480	-3%	-$1.51M	0.14%	161
2013 Q4	$42.1M	Sell	316,623 -21,955	-6%	-$2.63M	0.12%	169
2013 Q3	$39.3M	Sell	338,578 -9,422	-3%	-$1.03M	0.12%	170
2013 Q2	$32.1M	Buy	+348,000	New	+$33.5M	0.1%	188

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return